Ronald Olivenstein

Ronald Olivenstein, MD is an Associate Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University. He serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, specifically within the Translational Research in Respiratory Diseases Program. His clinical affiliation is with the Department of Medicine, Division of Respiratory Medicine at the McGill University Health Centre (MUHC).

Dr. Olivenstein's primary research focuses on asthma and chronic obstructive pulmonary disease (COPD). His work encompasses clinical trials in asthma and COPD, investigations into airway inflammation in severe asthma, and innovative therapies such as bronchial thermoplasty. He has collaborated extensively with pharmaceutical industry partners to test novel therapeutic agents in asthma and has helped establish a well-characterized severe asthma cohort at the Montreal Chest Institute. His research spans molecular mechanisms of airway inflammation, biomarker discovery, and evaluation of new interventions for respiratory diseases.

An analysis of Dr. Olivenstein's recent publications reveals a strong focus on severe asthma phenotypes, particularly eosinophilic inflammation and airway remodeling. His work frequently examines the role of biologic therapies like benralizumab in severe asthma management. More recent research has expanded into small airway dysfunction, molecular signaling pathways in asthma pathogenesis (including Wnt signaling and mitophagy), and potential biomarkers for asthma. His collaborative approach is evident through numerous multi-center clinical trials and translational research projects.